COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease
Modern Rheumatology · 2023
DOI: 10.1093/mr/roac074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Aslihan Avanoglu Guler und 13 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine Hospital, Department of Rheumatology, Gazi University, Ankara, Turkey. Hauptthemen laut MEDLINE: Familial Mediterranean Fever, COVID-19, Arthritis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
To evaluate the impact of familial Mediterranean fever (FMF) features on the clinical course and outcomes of coronavirus disease 2019 (COVID-19) and clinical course of FMF after COVID-19.
Methods
Consecutive FMF patients with COVID-19 were enrolled from three referral hospitals. Clinical features of FMF and detailed COVID-19 information were obtained from patient interviews and medical records.
Results
Seventy-three FMF patients were included in the study. 94.5% of patients had clinical symptoms of COVID-19. We found 24.7% hospitalization, 12.3% respiratory support, 4.1% intensive care unit admission, 6.8% complication, and 1.4% mortality rate in patients. The risk factors of hospitalization for respiratory support were male gender [OR: 7.167 (95% CI: 1.368–37.535)], greater age [OR: 1.067 (95% CI: 1.016–1.121)], and non-adherence to colchicine treatment before the infection [OR: 7.5 (95% CI: 1.348–41.722)]. One-third of patients had reported attacks after COVID-19. The patterns of triggered attacks were fever, peritonitis, pleuritis, transient arthritis, chronic knee mono-arthritis, and protracted febrile myalgia.
Conclusions
FMF characteristics were not associated with worse outcomes of COVID-19. Colchicine non-adherence was the risk factor of hospitalization for oxygen support. The rate of FMF attacks after COVID-19 is prominently increased, with some of them being protracted and destructive.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine Hospital, Department of Rheumatology, Gazi University, Ankara, Turkey.
- Faculty of Medicine Hospital, Department of Rheumatology, Dokuz Eylul University, Izmir, Turkey.
- Faculty of Medicine Hospital, Department of Rheumatology, Eskisehir Osmangazi University, Eskisehir, Turkey.
- Faculty of Medicine Hospital, Department of Internal Medicine, Gazi University, Ankara, Tukey.
ORCID-Profile: Aslihan Avanoglu Guler, Tuba Yuce Inel
Zitieren
APA
Avanoglu Guler, A., Yuce Inel, T., Kasifoglu, T., Coskun, C., Karadeniz, H., Yildirim, D., Bilici, R., Satis, H., Kucuk, H., Haznedaroglu, S., Goker, B., Ozturk, M. A., Sari, I., & Tufan, A. (2023). COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease. Modern Rheumatology. https://doi.org/10.1093/mr/roac074
Vancouver
Avanoglu Guler A, Yuce Inel T, Kasifoglu T, Coskun C, Karadeniz H, Yildirim D, et al. COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease. Modern Rheumatology. 2023. doi:10.1093/mr/roac074
BibTeX
@article{AvanogluGuler2023,
author = {Avanoglu Guler, Aslihan and Yuce Inel, Tuba and Kasifoglu, Timucin and Coskun, Cansu and Karadeniz, Hazan and Yildirim, Derya and Bilici, Reyhan and Satis, Hasan and Kucuk, Hamit and Haznedaroglu, Seminur and Goker, Berna and Ozturk, Mehmet Akif and Sari, Ismail and Tufan, Abdurrahman},
title = {COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease},
journal = {Modern Rheumatology},
year = {2023},
doi = {10.1093/mr/roac074}
}
EUVIMED